Enochian BioSciences Company
Enochian BioSciences is focusing on the clinical development of a dendritic cell vaccine for treatment of colorectal cancer.
Technology:
Cell therapy, Dendritic Cells
Industry:
Dendritic Cells, Public
Headquarters:
New York, New York, United States
Founded Date:
2011-01-01
Employees Number:
1-10
Funding Status:
IPO
Total Funding:
48000000
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-06-14
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership